Short answer
AMICUS THERAPEUTICS, INC. (FOLD) filed an 8-K current report with the SEC on April 23, 2026 reporting Item 8.01 (Other Events). French FDI clearance received April 23, 2026, satisfying the merger’s final regulatory condition.
AMICUS THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- French FDI clearance received April 23, 2026, satisfying the merger’s final regulatory condition
- BioMarin’s acquisition of Amicus expected to close April 27, 2026
- Amicus set to become a wholly owned BioMarin subsidiary following the merger
- Closing remains subject to customary conditions and carries timing and legal-process risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AMICUS THERAPEUTICS, INC. 8-K filings
Get the next FOLD 8-K as it lands
Follow FOLD for push alerts, or ask the research agent what this filing means.